why choose us

First received: October 22, 2022

Clinical Trial: Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Epilepsy; Seizure

Study Type: INTERVENTIONAL


Official Title: Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy

Brief Summary: This project studies how 2-deoxy-glucose (2DG) pills are absorbed and distributed in people with epilepsy.2DG is similar to glucose, the main energy source for the brain, but it cannot be used as energy.During seizures, neurons are at a very high metabolic state with huge glucose metabolism as glycolysis is accelerated to supply the high metabolic needs of a seizure.2DG is taken up by cells but cannot be metabolized by the first enzyme in the glycolytic pathway, thus is stops, or "clogs up",…

Read more